An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

PHASE2CompletedINTERVENTIONAL
Enrollment

2,080

Participants

Timeline

Start Date

September 6, 2007

Primary Completion Date

May 5, 2009

Study Completion Date

May 5, 2009

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

BEA 2180 BR

Solution

DRUG

Tiotropium Bromide

Solution

DRUG

Placebo

Solution

Trial Locations (178)

Unknown

1205.14.061 Boehringer Ingelheim Investigational Site, Jasper

1205.14.054 Boehringer Ingelheim Investigational Site, Mobile

1205.14.042 Boehringer Ingelheim Investigational Site, Berkeley

1205.14.017 Boehringer Ingelheim Investigational Site, La Jolla

1205.14.022 Boehringer Ingelheim Investigational Site, Lakewood

1205.14.046 Boehringer Ingelheim Investigational Site, Riverside

1205.14.008 Boehringer Ingelheim Investigational Site, San Diego

1205.14.047 Boehringer Ingelheim Investigational Site, San Diego

1205.14.037 Boehringer Ingelheim Investigational Site, Sepulveda

1205.14.041 Boehringer Ingelheim Investigational Site, Denver

1205.14.027 Boehringer Ingelheim Investigational Site, Fort Collins

1205.14.034 Boehringer Ingelheim Investigational Site, Wheat Ridge

1205.14.050 Boehringer Ingelheim Investigational Site, Stamford

1205.14.013 Boehringer Ingelheim Investigational Site, Bay Pines

1205.14.016 Boehringer Ingelheim Investigational Site, Clearwater

1205.14.048 Boehringer Ingelheim Investigational Site, DeLand

1205.14.043 Boehringer Ingelheim Investigational Site, Panama City

1205.14.040 Boehringer Ingelheim Investigational Site, Tampa

1205.14.007 Boehringer Ingelheim Investigational Site, Atlanta

1205.14.053 Boehringer Ingelheim Investigational Site, Stockbridge

1205.14.014 Boehringer Ingelheim Investigational Site, Coeur d'Alene

1205.14.035 Boehringer Ingelheim Investigational Site, Olathe

1205.14.057 Boehringer Ingelheim Investigational Site, New Orleans

1205.14.052 Boehringer Ingelheim Investigational Site, Shreveport

1205.14.036 Boehringer Ingelheim Investigational Site, Ann Arbor

1205.14.019 Boehringer Ingelheim Investigational Site, Livonia

1205.14.018 Boehringer Ingelheim Investigational Site, Chesterfield

1205.14.032 Boehringer Ingelheim Investigational Site, St Louis

1205.14.033 Boehringer Ingelheim Investigational Site, Reno

1205.14.044 Boehringer Ingelheim Investigational Site, Brick

1205.14.056 Boehringer Ingelheim Investigational Site, Cherry Hill

1205.14.058 Boehringer Ingelheim Investigational Site, Summit

1205.14.010 Boehringer Ingelheim Investigational Site, Albuquerque

1205.14.062 Boehringer Ingelheim Investigational Site, Larchmont

1205.14.028 Boehringer Ingelheim Investigational Site, Mineola

1205.14.030 Boehringer Ingelheim Investigational Site, New Hyde Park

1205.14.021 Boehringer Ingelheim Investigational Site, New York

1205.14.059 Boehringer Ingelheim Investigational Site, Toledo

1205.14.012 Boehringer Ingelheim Investigational Site, Oklahoma City

1205.14.031 Boehringer Ingelheim Investigational Site, Medford

1205.14.003 Boehringer Ingelheim Investigational Site, Philadelphia

1205.14.004 Boehringer Ingelheim Investigational Site, Pittsburgh

1205.14.005 Boehringer Ingelheim Investigational Site, Johnston

1205.14.029 Boehringer Ingelheim Investigational Site, Charleston

1205.14.055 Boehringer Ingelheim Investigational Site, Greer

1205.14.020 Boehringer Ingelheim Investigational Site, Spartanburg

1205.14.045 Boehringer Ingelheim Investigational Site, Fort Worth

1205.14.025 Boehringer Ingelheim Investigational Site, Houston

1205.14.060 Boehringer Ingelheim Investigational Site, Killeen

1205.14.002 Boehringer Ingelheim Investigational Site, San Antonio

1205.14.023 Boehringer Ingelheim Investigational Site, Richmond

1205.14.024 Boehringer Ingelheim Investigational Site, Richmond

1205.14.026 Boehringer Ingelheim Investigational Site, Roanoke

1205.14.009 Boehringer Ingelheim Investigational Site, Spokane

1205.14.039 Boehringer Ingelheim Investigational Site, Spokane

1205.14.001 Boehringer Ingelheim Investigational Site, Morgantown

1205.14.151 Boehringer Ingelheim Investigational Site, Edmonton

1205.14.144 Boehringer Ingelheim Investigational Site, Vancouver

1205.14.148 Boehringer Ingelheim Investigational Site, St. John's

1205.14.143 Boehringer Ingelheim Investigational Site, Burlington

1205.14.142 Boehringer Ingelheim Investigational Site, Downsview

1205.14.150 Boehringer Ingelheim Investigational Site, Grimsby

1205.14.149 Boehringer Ingelheim Investigational Site, Mississauga

1205.14.146 Boehringer Ingelheim Investigational Site, Québec

1205.14.145 Boehringer Ingelheim Investigational Site, Sherbrooke

1205.14.381 Boehringer Ingelheim Investigational Site, Aschaffenburg

1205.14.164 Boehringer Ingelheim Investigational Site, Berlin

1205.14.167 Boehringer Ingelheim Investigational Site, Berlin

1205.14.168 Boehringer Ingelheim Investigational Site, Berlin

1205.14.172 Boehringer Ingelheim Investigational Site, Berlin

1205.14.175 Boehringer Ingelheim Investigational Site, Berlin

1205.14.177 Boehringer Ingelheim Investigational Site, Berlin

1205.14.178 Boehringer Ingelheim Investigational Site, Berlin

1205.14.377 Boehringer Ingelheim Investigational Site, Berlin

1205.14.382 Boehringer Ingelheim Investigational Site, Berlin

1205.14.387 Boehringer Ingelheim Investigational Site, Berlin

1205.14.388 Boehringer Ingelheim Investigational Site, Berlin

1205.14.165 Boehringer Ingelheim Investigational Site, Bonn

1205.14.176 Boehringer Ingelheim Investigational Site, Cottbus

1205.14.171 Boehringer Ingelheim Investigational Site, Dortmund

1205.14.379 Boehringer Ingelheim Investigational Site, Geesthacht

1205.14.174 Boehringer Ingelheim Investigational Site, Gelnhausen

1205.14.173 Boehringer Ingelheim Investigational Site, Hamburg

1205.14.375 Boehringer Ingelheim Investigational Site, Hanover

1205.14.378 Boehringer Ingelheim Investigational Site, Koblenz

1205.14.170 Boehringer Ingelheim Investigational Site, Lübeck

1205.14.162 Boehringer Ingelheim Investigational Site, Mainz

1205.14.384 Boehringer Ingelheim Investigational Site, Marburg

1205.14.166 Boehringer Ingelheim Investigational Site, Minden

1205.14.372 Boehringer Ingelheim Investigational Site, Neumünster

1205.14.386 Boehringer Ingelheim Investigational Site, Neuruppin

1205.14.385 Boehringer Ingelheim Investigational Site, Oschersleben

1205.14.169 Boehringer Ingelheim Investigational Site, Rüdersdorf

1205.14.179 Boehringer Ingelheim Investigational Site, Rüsselsheim am Main

1205.14.376 Boehringer Ingelheim Investigational Site, Saarbrücken

1205.14.374 Boehringer Ingelheim Investigational Site, Schwetzingen

1205.14.371 Boehringer Ingelheim Investigational Site, Witten

1205.14.373 Boehringer Ingelheim Investigational Site, Witten

1205.14.279 Boehringer Ingelheim Investigational Site, Budakeszi

1205.14.273 Boehringer Ingelheim Investigational Site, Budapest

1205.14.283 Boehringer Ingelheim Investigational Site, Budapest

1205.14.287 Boehringer Ingelheim Investigational Site, Budapest

1205.14.286 Boehringer Ingelheim Investigational Site, Cegléd

1205.14.281 Boehringer Ingelheim Investigational Site, Debrecen

1205.14.272 Boehringer Ingelheim Investigational Site, Deszk

1205.14.289 Boehringer Ingelheim Investigational Site, Deszk

1205.14.271 Boehringer Ingelheim Investigational Site, Érd

1205.14.276 Boehringer Ingelheim Investigational Site, Gödöllö

1205.14.282 Boehringer Ingelheim Investigational Site, Gyula

1205.14.277 Boehringer Ingelheim Investigational Site, Komárom

1205.14.278 Boehringer Ingelheim Investigational Site, Mátraháza

1205.14.280 Boehringer Ingelheim Investigational Site, Mosonmagyaróvár

1205.14.285 Boehringer Ingelheim Investigational Site, Sopron

1205.14.275 Boehringer Ingelheim Investigational Site, Szarvas

1205.14.288 Boehringer Ingelheim Investigational Site, Százhalombatta

1205.14.284 Boehringer Ingelheim Investigational Site, Tatabánya

1205.14.274 Boehringer Ingelheim Investigational Site, Zalaegerszeg

1205.14.108 Boehringer Ingelheim Investigational Site, Cuernavaca, Mor. México

1205.14.101 Boehringer Ingelheim Investigational Site, Hermosillo, Sonora

1205.14.119 Boehringer Ingelheim Investigational Site, Metepec

1205.14.117 Boehringer Ingelheim Investigational Site, Mexico City

1205.14.120 Boehringer Ingelheim Investigational Site, Mexico City

1205.14.102 Boehringer Ingelheim Investigational Site, Monterrey

1205.14.116 Boehringer Ingelheim Investigational Site, Monterrey, Nuevo León

1205.14.105 Boehringer Ingelheim Investigational Site, Zapopan, Jal.

1205.14.251 Boehringer Ingelheim Investigational Site, Chrzanów

1205.14.253 Boehringer Ingelheim Investigational Site, Gdansk

1205.14.254 Boehringer Ingelheim Investigational Site, Gdansk

1205.14.246 Boehringer Ingelheim Investigational Site, Krakow

1205.14.241 Boehringer Ingelheim Investigational Site, Lodz

1205.14.242 Boehringer Ingelheim Investigational Site, Lodz

1205.14.255 Boehringer Ingelheim Investigational Site, Miechów

1205.14.248 Boehringer Ingelheim Investigational Site, Ruda Śląska

1205.14.249 Boehringer Ingelheim Investigational Site, Tarnowskie Góry

1205.14.252 Boehringer Ingelheim Investigational Site, Wilkowice

1205.14.243 Boehringer Ingelheim Investigational Site, Wroclaw

1205.14.244 Boehringer Ingelheim Investigational Site, Wroclaw

1205.14.245 Boehringer Ingelheim Investigational Site, Wroclaw

1205.14.247 Boehringer Ingelheim Investigational Site, Zabrze

1205.14.301 Boehringer Ingelheim Investigational Site, Moscow

1205.14.302 Boehringer Ingelheim Investigational Site, Moscow

1205.14.303 Boehringer Ingelheim Investigational Site, Moscow

1205.14.304 Boehringer Ingelheim Investigational Site, Moscow

1205.14.305 Boehringer Ingelheim Investigational Site, Moscow

1205.14.306 Boehringer Ingelheim Investigational Site, Moscow

1205.14.310 Boehringer Ingelheim Investigational Site, Saint Petersburg

1205.14.311 Boehringer Ingelheim Investigational Site, Saint Petersburg

1205.14.312 Boehringer Ingelheim Investigational Site, Saint Petersburg

1205.14.313 Boehringer Ingelheim Investigational Site, Saint Petersburg

1205.14.314 Boehringer Ingelheim Investigational Site, Saint Petersburg

1205.14.307 Boehringer Ingelheim Investigational Site, Yaroslavl

1205.14.308 Boehringer Ingelheim Investigational Site, Yaroslavl

1205.14.309 Boehringer Ingelheim Investigational Site, Yaroslavl

1205.14.225 Boehringer Ingelheim Investigational Site, Gyeonggi-do

1205.14.228 Boehringer Ingelheim Investigational Site, Gyeonggi-do

1205.14.227 Boehringer Ingelheim Investigational Site, Seongdong-gu

1205.14.221 Boehringer Ingelheim Investigational Site, Seoul

1205.14.222 Boehringer Ingelheim Investigational Site, Seoul

1205.14.223 Boehringer Ingelheim Investigational Site, Seoul

1205.14.224 Boehringer Ingelheim Investigational Site, Seoul

1205.14.226 Boehringer Ingelheim Investigational Site, Seoul

1205.14.182 Boehringer Ingelheim Investigational Site, Badajoz

1205.14.186 Boehringer Ingelheim Investigational Site, Cáceres

1205.14.183 Boehringer Ingelheim Investigational Site, Madrid

1205.14.191 Boehringer Ingelheim Investigational Site, Málaga

1205.14.181 Boehringer Ingelheim Investigational Site, Terrassa (Barcelona)

1205.14.190 Boehringer Ingelheim Investigational Site, Torrevieja

1205.14.189 Boehringer Ingelheim Investigational Site, Valencia

1205.14.187 Boehringer Ingelheim Investigational Site, Vigo

1205.14.207 Boehringer Ingelheim Investigational Site, Changhua

1205.14.208 Boehringer Ingelheim Investigational Site, Chiayi City

1205.14.210 Boehringer Ingelheim Investigational Site, Kaohsiung City

1205.14.209 Boehringer Ingelheim Investigational Site, Kaohsiung County

1205.14.205 Boehringer Ingelheim Investigational Site, Taichung

1205.14.206 Boehringer Ingelheim Investigational Site, Taichung

1205.14.202 Boehringer Ingelheim Investigational Site, Taipei

1205.14.204 Boehringer Ingelheim Investigational Site, Taipei

1205.14.201 Boehringer Ingelheim Investigational Site, Taoyuan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00528996 - An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. | Biotech Hunter | Biotech Hunter